(Q39918594)

15 September 2017

Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone (English)

1 reference

15 September 2017

1 reference

7

Jian Zhang

1 reference

15 September 2017

Yi Lu

1

1 reference

15 September 2017

Qiuyan Chen

2

1 reference

15 September 2017

Eva Corey

3

1 reference

15 September 2017

Wen Xie

4

1 reference

15 September 2017

Jie Fan

5

1 reference

15 September 2017

Atsushi Mizokami

6

1 reference

15 September 2017

11 November 2008

1 reference

Clinical & Experimental Metastasis

15 September 2017

1 reference

15 September 2017

26

1 reference

15 September 2017

2

1 reference

15 September 2017

161-169

1 reference

https://scigraph.springernature.com/pub.10.1007/s10585-008-9226-7

15 September 2017

0 references

cites work

Estrogen decreases expression of chemokine receptors, and suppresses chemokine bioactivity in murine monocytes

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10585-008-9226-7

CCL2 is a potent regulator of prostate cancer cell migration and proliferation

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10585-008-9226-7

Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.

21 January 2018

1 reference

12 December 2020

Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis

1 reference

12 December 2020

Molecular Mechanisms of Bone Metastasis and Therapeutic Implications

1 reference

12 December 2020

CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor

1 reference

12 December 2020

Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone

1 reference

12 December 2020

A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan

1 reference

12 December 2020

Mechanisms of bone metastasis

1 reference

12 December 2020

The role of tumor microenvironment in prostate cancer bone metastasis

1 reference

12 December 2020

A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF)

1 reference

12 December 2020

Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression

1 reference

12 December 2020

Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion.

1 reference

12 December 2020

Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone

1 reference

12 December 2020

The evolving biology and treatment of prostate cancer

1 reference

12 December 2020

PTHrP-induced MCP-1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro

1 reference

12 December 2020

CCR2 expression correlates with prostate cancer progression

1 reference

12 December 2020

Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients

1 reference

12 December 2020

Crosstalk between cancer cells and bone microenvironment in bone metastasis

1 reference

12 December 2020

Chemokines induce migrational responses in human breast carcinoma cell lines

1 reference

12 December 2020

Involvement of chemokine receptors in breast cancer metastasis

1 reference

12 December 2020

Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours

1 reference

12 December 2020

Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer

1 reference

12 December 2020

Monocyte chemotactic protein-1 (MCP-1): signal transduction and involvement in the regulation of macrophage traffic in normal and neoplastic tissues

1 reference

12 December 2020

Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption

1 reference

12 December 2020

VIth meeting on cancer-induced bone disease

1 reference

12 December 2020

Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus

1 reference

12 December 2020

Metastatic breast cancer induces an osteoblast inflammatory response

1 reference

12 December 2020

Prostate carcinoma skeletal metastases: cross-talk between tumor and bone.

1 reference

12 December 2020

Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression

1 reference

12 December 2020

Chemokine receptor expression by human intestinal epithelial cells

1 reference

12 December 2020

Serum cytokine concentrations in patients with cervical cancer: interleukin-4, interferon-gamma, and monocyte chemoattractant protein-1

1 reference

12 December 2020

Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3.

1 reference

12 December 2020

Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo

1 reference

12 December 2020

CCL2 (monocyte chemoattractant protein-1) and cancer

1 reference

12 December 2020

CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells

1 reference

12 December 2020

Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone

1 reference

12 December 2020

10.1007/S10585-008-9226-7

Identifiers

DOI

1 reference

15 September 2017

1 reference